Company Filing History:
11 out of 902 
4 out of 3,439 
4 out of 41 Years Active: 2001-2013
Title: The Innovative Contributions of Joel N Kline
Introduction
Joel N Kline is a prominent inventor based in Iowa City, IA, known for his significant contributions to the field of pulmonary disease treatment. With a total of 13 patents to his name, Kline has made remarkable strides in medical research and therapeutic methods.
Latest Patents
Among his latest patents, Kline has developed methods for treating pulmonary diseases and disorders by modulating calcium/calmodulin dependent protein kinase II activity. These methods involve administering an effective amount of a compound that inhibits Calmodulin Kinase II (CaMKII) activity, thereby treating or preventing pulmonary diseases in subjects. Additionally, he has patented immunostimulatory nucleic acid molecules that contain unmethylated CpG dinucleotides. These nucleic acids have therapeutic utilities based on their ability to stimulate an immune response and redirect a Th2 response to a Th1 response in subjects, including methods for treating atopic diseases such as atopic dermatitis.
Career Highlights
Kline has had a distinguished career, working with esteemed organizations such as the University of Iowa Research Foundation and the National Institutes of Health, a component of the US Department of Health & Human Services. His work has significantly impacted the understanding and treatment of various pulmonary conditions.
Collaborations
Throughout his career, Kline has collaborated with notable colleagues, including Arthur Mertz Krieg and Dennis M Klinman. These collaborations have further enhanced the scope and impact of his research.
Conclusion
Joel N Kline's innovative work in the field of pulmonary disease treatment exemplifies the importance of research and development in medicine. His contributions continue to influence therapeutic approaches and improve patient outcomes.